Laon Medi has entered into a strategic partnership with dental orthodontic materials distributor Kwangmyung Daycom to expand its presence in the domestic clear aligner market. Through this collaboration, Laon Medi will provide its proprietary digital orthodontic software, Laon Ortho, across Kwangmyung Daycom’s nationwide distribution network, significantly enhancing market reach and sales opportunities. Kwangmyung Daycom is also expected to strengthen its competitiveness by expanding beyond traditional orthodontic materials into digital orthodontics and clear aligner solutions. By combining AI-driven digital technology with a strong distribution infrastructure, the two companies aim to accelerate the digital transformation of the orthodontic market and unlock new business opportunities. Laon Medi will continue to build a comprehensive digital orthodontic ecosystem through strategic partnerships and further solidify its position in both domestic and global markets.

AI-based medical solution company Laon Medi has signed an agreement with Graphy, a specialized 3D printing medical materials company, to commercialize a next-generation clear aligner platform and expand its global business. Through this collaboration, Laon Medi aims to integrate its AI-based orthodontic design software with Graphy’s advanced 3D printing materials and manufacturing technologies to develop and commercialize a next-generation digital orthodontic platform for the global market. Previously, the two companies entered into a Memorandum of Understanding (MOU) in October last year for the joint development of an AI-based orthodontic solution. After approximately six months of R\&D, the platform is now in the final stages of system development, with pilot operations planned ahead of a global launch. The upcoming platform combines Laon Medi’s CBCT-based root analysis and 3D visualization capabilities with Graphy’s shape-memory resin and 3D printing technologies. It enables precise simulation of complex tooth movements and significantly simplifies conventional manual workflows into a “one-click” level through automation. In particular, the platform is designed as a fully integrated “One-stop” system, covering the entire process from order intake and AI-based treatment setup to aligner design and final production via 3D printing. This is expected to reduce lead time and establish a scalable mass production system. A representative from Laon Medi stated, “Through our collaboration with Graphy, we have enhanced the completeness of our digital orthodontic platform while securing both scalability and productivity required for the global market. We plan to expand our presence in key markets including the U.S. and Japan.” Meanwhile, Laon Medi continues to strengthen its global footprint with its AI-based dental software, Laon Ortho, gaining recognition for its technology and clinical applicability through major exhibitions and academic conferences.

AI medical technology company Laon Medi is expanding its global business by entering the Japanese orthodontic market, following its U.S. market entry after obtaining FDA clearance. Laon Medi announced on the 12th that it has signed a distribution agreement with Corefront, a Japanese medical device distribution company. Through this partnership, Laon Medi is accelerating procedures including registration as a foreign medical device manufacturer, regulatory approvals, and registration with Japan’s Ministry of Health, Labour and Welfare (MHLW). Starting this year, the company will begin full-scale distribution and sales of its AI-based orthodontic setup software, Laon Ortho, in Japan. AI-integrated medical technologies—particularly AI-based dental software—are gaining strong traction in the global market. Following its entry into the U.S., which holds significant influence and market share in the global orthodontics sector, Laon Medi’s expansion into Japan is enabling rapid growth of its international sales network. A Laon Medi representative stated, “Participation in domestic and international dental exhibitions and the establishment of country-specific distribution channels have played a positive role in promoting our AI dental software and increasing awareness of products such as Laon Ortho. Through continued technological advancement and localization, we aim to increase market share in both the U.S. and Japan, while preparing to expand into Southeast Asia and China, where orthodontic markets are rapidly growing, supported by global regulatory approvals.” A representative from Corefront commented, “Even in Japan, which is known for its conservative approach to medical technology adoption, K-medi products have been highly evaluated for their technical excellence and clinical effectiveness. Laon Medi’s fast AI analysis, one-click diagnosis, and digital orthodontic solutions—already clinically validated—align well with the core strengths of K-medi, leading us to see strong potential in the Japanese orthodontic market.” Meanwhile, Laon Medi—selected as a promising SME by Gyeonggi Province—has obtained U.S. FDA clearance for its medical device and entered the U.S. market through a partnership with dental materials company Uclear. The company has also received recognition from orthodontists for its technology and clinical usability at major dental exhibitions and academic conferences, further strengthening its prospects for success in global markets, including Japan.